Virax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) was the recipient of a significant drop in short interest in January. As of January 15th, there was short interest totalling 109,000 shares, a drop of 33.9% from the December 31st total of 164,900 shares. Currently, 2.7% of the company’s stock are sold short. Based on an average daily trading volume, of 1,800,000 shares, the short-interest ratio is presently 0.1 days.
Virax Biolabs Group Price Performance
Shares of NASDAQ:VRAX remained flat at $1.69 during midday trading on Friday. 119,104 shares of the stock traded hands, compared to its average volume of 351,737. Virax Biolabs Group has a one year low of $0.60 and a one year high of $9.00. The business’s 50 day moving average price is $2.03 and its 200 day moving average price is $2.21.
Virax Biolabs Group Company Profile
Recommended Stories
- Five stocks we like better than Virax Biolabs Group
- What is a support level?
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- Overbought Stocks Explained: Should You Trade Them?
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Virax Biolabs Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virax Biolabs Group and related companies with MarketBeat.com's FREE daily email newsletter.